Mitchell E. Gross, MD, PhD

Dr. Gross is research director of the USC Norris Westside Cancer Center and the Center for Applied Molecular Medicine. His overall research interest focuses on applying modern techniques relating to the study of genes and proteins (genomics and proteomics) on the clinical problems faced in treating patients with prostate cancer. A particular interest relates to the androgen receptor and relating proteins and pathways as key driving forces behind the development and treatment of prostate cancer. As a medical oncologist, his clinical activities are focused on therapeutic clinical trials incorporating both molecularly targeted and conventional therapies to the care of patients with prostate cancer. He serves as primary investigator on many multi-center phase 1 and 2 clinical trials

Dr. Gross has earned degrees from the University of California, San Diego (B.A.), Baylor College of Medicine in Houston (M.D.), and the University of California, Los Angeles (Ph.D. Molecular Biology). He completed a residency in internal medicine and a fellowship in hematology and medical oncology at the UCLA Center for the Health Sciences.

• Phi Beta Kappa, 1989
• UCSD/Revelle College Academic: Leadership Award, 1990
• Alpha Omega Alpha, 1994
• Hewlett Packard Award for Excellence in Internal Medicine, 1994
• Specialty Training Advanced Research Fellowship, 1997
   – 2002
• Amgen Fellowship Research Award, 1999
• Rhone Phoulenc Rorer Travel Award, 1999
• AACR-AFLAC Scholar in Training Award,, 2001
• Donna and Jesse Garber Award, 2006

• Selective Cancer Treatment Based on High Frequency Ultrasonic Beam
  NIH · R21EB022932 · Sep 16, 2016 – Jul 31, 2018 · Role: Co-Principal Investigator
• Role of PIASy in Androgen Signaling and Prostate Cancer
  NIH · K08DK064379 · Aug 21, 2002 – Jun 30, 2007 · Role: Principal Investigator

• Lenz, Heinz-Josef
• Quinn, David
• Jadvar, Hossein
• Gill, Inderbir
• Haiman, Christopher
• Goldkorn, Amir